Interestingly, adding it to coffee is one of them
Regarding the safety profile of semaglutide 2.4 mg, the STEP programme highlighted an AE incidence ranging between 84.3% and 96.1% among treated participants, compared with 75.0%96.1% in placebo groups [13, 38,39,40,41,42,43,44,45,46]
Peak severity: Weeks 4 to 12, often worsening with each dose increase
Do not leave vials on a bathroom counter or windowsill where they receive direct or indirect sunlight
Other GLP-1s Practical Considerations Most newer GLP-1 medications offer the convenience of weekly injections, including tirzepatide, Wegovy, and Trulicity
List price for GLP-1 drugs in the U.S